1492 Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-243
| Closed | -$255K | – | 119 |
|
|
2024
Q3 | $255K | Sell |
243
-5
| -2% | -$5.26K | 0.13% | 77 |
|
|
2024
Q2 | $261K | Buy |
248
+23
| +10% | +$24.2K | 0.15% | 72 |
|
|
2024
Q1 | $217K | Sell |
225
-13
| -5% | -$12.5K | 0.12% | 86 |
|
|
2023
Q4 | $209K | Sell |
238
-11
| -4% | -$9.66K | 0.12% | 93 |
|
|
2023
Q3 | $205K | Buy |
+249
| New | +$205K | 0.13% | 86 |
|
|
2023
Q2 | – | Sell |
-249
| Closed | -$205K | – | 112 |
|
|
2023
Q1 | $205K | Buy |
+249
| New | +$205K | 0.13% | 92 |
|
|
2022
Q4 | – | Sell |
-301
| Closed | -$207K | – | 117 |
|
|
2022
Q3 | $207K | Buy |
+301
| New | +$207K | 0.15% | 93 |
|